These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33244333)

  • 1. [CD10 expression in stromal cells of patients with breast cancer: a poor prognostic marker].
    Bacha D; Amor AB; Farhat FB; Slama SB; Lahmar A; Bouraoui S; Triki A
    Pan Afr Med J; 2020; 37():70. PubMed ID: 33244333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal CD10 expression in breast cancer correlates with tumor invasion and cancer stem cell phenotype.
    Louhichi T; Saad H; Dhiab MB; Ziadi S; Trimeche M
    BMC Cancer; 2018 Jan; 18(1):49. PubMed ID: 29306324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.
    Makretsov NA; Hayes M; Carter BA; Dabiri S; Gilks CB; Huntsman DG
    Mod Pathol; 2007 Jan; 20(1):84-9. PubMed ID: 17143263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of CD10 expression in clinical outcome of invasive breast carcinoma.
    Vo TN; Mekata E; Umeda T; Abe H; Kawai Y; Mori T; Kubota Y; Shiomi H; Naka S; Shimizu T; Murata S; Yamamoto H; Ishida M; Tani T
    Breast Cancer; 2015 Mar; 22(2):117-28. PubMed ID: 23575921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
    Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
    Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD10-a new prognostic stromal marker in breast carcinoma, its utility, limitations and role in breast cancer pathogenesis.
    Jana SH; Jha BM; Patel C; Jana D; Agarwal A
    Indian J Pathol Microbiol; 2014; 57(4):530-6. PubMed ID: 25308002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of neoadjuvant chemotherapy on stromal CD10 antigens in breast cancer - a preliminary study.
    Thomas S; Babu RJ; Agarwal K; Puri V; Jain M; Andley M; Tudu SK
    Indian J Cancer; 2013; 50(1):46-51. PubMed ID: 23713046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of CD10 positivity of stromal cells in core needle biopsy specimen of breast cancer patients and its relation with histological grade and lymphovascular invasion.
    Boler AK; Akhtar S; Bandyopadhyay A; Bandyopadhyay G
    Indian J Pathol Microbiol; 2021; 64(3):460-463. PubMed ID: 34341253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stromal expression of CD10 in invasive breast carcinoma and its association with tumour stage, grade, ER, PR and HER2 status.
    Kamarudin NA; Abd Shukor N; Farouk WI; Muhammad Hanapi NA; Mohammed F
    Malays J Pathol; 2021 Dec; 43(3):389-396. PubMed ID: 34958060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD10 expression in epithelial and stromal cells of non-small cell lung carcinoma (NSCLC): a clinic and pathologic correlation.
    Gürel D; Kargı A; Karaman I; Onen A; Unlü M
    Pathol Oncol Res; 2012 Apr; 18(2):153-60. PubMed ID: 21681600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and clinical evaluation of CD10+ stroma cells in the breast cancer microenvironment.
    Desmedt C; Majjaj S; Kheddoumi N; Singhal SK; Haibe-Kains B; El Ouriaghli F; Chaboteaux C; Michiels S; Lallemand F; Journe F; Duvillier H; Loi S; Quackenbush J; Dekoninck S; Blanpain C; Lagneaux L; Houhou N; Delorenzi M; Larsimont D; Piccart M; Sotiriou C
    Clin Cancer Res; 2012 Feb; 18(4):1004-14. PubMed ID: 22235100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low CD10 mRNA expression identifies high-risk ductal carcinoma in situ (DCIS).
    Toussaint J; Durbecq V; Altintas S; Doriath V; Rouas G; Paesmans M; Bedard P; Haibe-Kains B; Tjalma WA; Larsimont D; Piccart M; Sotiriou C
    PLoS One; 2010 Aug; 5(8):. PubMed ID: 20856894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical appraisal of stromal CD10 staining in fibroepithelial lesions of breast with a special emphasis on expression patterns and correlation with WHO grading.
    Puri V; Jain M; Mahajan G; Pujani M
    J Cancer Res Ther; 2016; 12(2):667-70. PubMed ID: 27461629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing CD 10 Expression Level and Its Prognostic Impact in Egyptian Patients with Urothelial Carcinoma.
    Hussien MT; Helmy E; Elsaba TM; Elkady A; Alrefai H; Hetta HF
    Asian Pac J Cancer Prev; 2020 Jun; 21(6):1573-1583. PubMed ID: 32592351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Significance of CD10 Expression in Invasive Breast Carcinoma in Tunisian Patients.
    Makni S; Mellouli M; Saguem I; Boudawara O; Gouiaa N; Boudawara TS; Feki J; Kallel R
    Gulf J Oncolog; 2022 Sep; 1(40):15-23. PubMed ID: 36448066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD10 Immunohistochemical Expression in Predicting Aggressive Behavior of Phylloides Tumors.
    Tariq MU; Haroon S; Kayani N
    Asian Pac J Cancer Prev; 2015; 16(8):3147-52. PubMed ID: 25921112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients.
    Martinez LM; Labovsky V; Calcagno ML; Davies KM; Garcia Rivello H; Bianchi MS; Wernicke A; Fernández Vallone VB; Chasseing NA
    PLoS One; 2015; 10(3):e0121421. PubMed ID: 25803686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stromal CD10 expression and relationship to the E-cadherin/beta-catenin complex in breast carcinoma.
    Kim HS; Kim GY; Kim YW; Park YK; Song JY; Lim SJ
    Histopathology; 2010 May; 56(6):708-19. PubMed ID: 20546336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD10-positive stromal cells in gastric carcinoma: correlation with invasion and metastasis.
    Huang WB; Zhou XJ; Chen JY; Zhang LH; Meng K; Ma HH; Lu ZF
    Jpn J Clin Oncol; 2005 May; 35(5):245-50. PubMed ID: 15886270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD10 and E-cad expression in urinary bladder urothelial and squamous cell carcinoma.
    Omran OM
    J Environ Pathol Toxicol Oncol; 2012; 31(3):203-12. PubMed ID: 23339695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.